Global CAR T-cell Therapy Market 2018-2022
About CAR T-cell Therapy
Chimeric antigen receptor (CAR) is one of the recent innovations in the pharmaceutical industry for the treatment of serious, life-threatening diseases, typically in the areas of oncology. CARs are engineered receptors to attack cancer cells. In this therapy, patients’ T-cells are modified to attack cancer cells. In this therapy, patients’ T-cells are modified in the laboratory to fight against various cancer indications.
Technavio’s analysts forecast the Global CAR T-cell Therapy Market to grow at a CAGR of 63.15% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the CAR T-cell therapy market. To calculate the market size, the report considers the revenue generated from the application of CAR T-cell therapy across the globe.
The market is divided into the following segments based on geography:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook